发明名称 |
Use of Glycopyrrolate for Treating Tachycardia |
摘要 |
The invention relates to a novel use of the antimuscarinic agent glycopyrrolate, for example the salt glycopyrronium bromide. In particular, the invention relates to glycopyrrolate for use as a heart rate lowering agent and more particularly, but not exclusively, for use in patients suffering from respiratory conditions such as chronic obstructive pulmonary disease. |
申请公布号 |
US2016143880(A1) |
申请公布日期 |
2016.05.26 |
申请号 |
US201615011582 |
申请日期 |
2016.01.31 |
申请人 |
Sosei R&D Ltd. |
发明人 |
SNAPE Susan;TANSLEY Robert |
分类号 |
A61K31/40;A61K31/4704;A61K9/00;A61K45/06 |
主分类号 |
A61K31/40 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treatment or prophylaxis of a condition or disorder characterised by an increased heart rate, said method comprising administering to a patient in need of such treatment or prophylaxis, an effective amount of an inhalable pharmaceutical composition comprising glycopyrrolate or a pharmaceutically acceptable salt thereof. |
地址 |
London GB |